ERBB2 and breast carcinoma: The disparate effects of Ccl2 versus Ccr2 disruption on the behavior of HER2/neu-driven mammary carcinomas could be due to the influence of other CCR2 ligands in CCL2-deficient mice or the effects of CCL2 on an as yet unidentified receptor in CCR2-deficient mice.